Oral bisphosphonates improve bone mineral density in adults with cystic fibrosis

Irish Medical Journal

Volumn 98, Issue 9, 2005, Pages 270-273

  Cawood, Tom J ^a   McKenna, M J ^a   Gallagher, C G ^a   Smith, D ^a   Wen, Y C ^a   Gibney, J ^a   Dodd, J D ^a   O'Shea, D ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALPHA TOCOPHEROL; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; PANCREAS ENZYME; RETINOL; RISEDRONIC ACID; VITAMIN D; VITAMIN K GROUP;

ADULT; ARTICLE; BONE DEMINERALIZATION; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; FOLLOW UP; HUMAN; LUMBAR SPINE; MALE; OSTEOPENIA; OSTEOPOROSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CASE-CONTROL STUDIES; CYSTIC FIBROSIS; DIPHOSPHONATES; FEMALE; HUMANS; MALE; OSTEOPOROSIS; RETROSPECTIVE STUDIES;

EID: 27944509177     PISSN: 03323102     EISSN: 03323102     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ratjen F, Doring G. Cystic fibrosis. Lancet 2003; 361:681-9.
2. Elborn JS, Shale DJ, Britton JR. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax 1991; 46:881-5.
3. Hanly JG, McKenna MJ, Quigley C, Freaney R, Muldowney FP, FitzGerald MX. Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis. Q J Med 1985; 56:377-85.
4. Moran A. Endocrine complications of cystic fibrosis. Adolesc Med 2002; 13:145-59, vii-viii.
5. Flohr F, Lutz A, App EM, Matthys H, Reincke M. Bone mineral density and quantitative ultrasound in adults with cystic fibrosis. Eur J Endocrinol 2002; 146:531-6.
6. Brenckmann C, Papaioannou A, Freitag A, et al. Osteoporosis in Canadian adult cystic fibrosis patients: A descriptive study. BMC Musculoskelet Disord 2003; 4:13.
7. Dodd JD, Barry SC, Masterson J, McKenna MJ, Gallagher CG. High prevalence of low bone mineral density, hypovitaminosis D and secondary hyperparathyroidism in adults with cystic fibrosis. Am J Respir Crit Care Med 2002:A284 Abstract.
8. Bhudhikanok GS, Wang MC, Marcus R, Harkins A, Moss RB, Bachrach LK. Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study. J Pediatr 1998; 133:18-27.
9. Henderson RC, Madsen CD. Bone density in children and adolescents with cystic fibrosis. J Pediatr 1996; 128:28-34.
10. Haworth CS, Selby PL, Horrocks AW, Mawer EB, Adams JE, Webb AK. A prospective study of change in bone mineral density over one year in adults with cystic fibrosis. Thorax 2002; 57:719-23.
11. Elkin SL, Fairney A, Burnett S, et al. Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int 2001; 12:366-72.
12. Aris RM, Renner JB, Winders AD, et al. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med 1998; 128:186-93.
13. Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 1998; 8:489-89.
14. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Report of WHO study group. WHO technical report, Geneva. 1994; Series 843.
15. Aris RM, Lester GE, Renner JB, et al. Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Am J Respir Crit Care Med 2000; 162:941-6.
16. Haworth CS, Selby PL, Adams JE, Mawer EB, Horrocks AW, Webb AK. Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis. Thorax 2001; 56:314-6.
17. Aris RM, Lester GE, Caminiti M, et al. Efficacy of Alendronate in Adults with Cystic Fibrosis with Low Bone Density. Am J Respir Crit Care Med 2004; 179:77-82.
18. International Society for Clinical Densitometry. Position Statements. www.iscd.org.
19. Hecker TM, Aris RM. Management of osteoporosis in adults with cystic fibrosis. Drugs 2004; 64:133-47.
20. Aris RM, Ontjes DA, Buell HE, et al. Abnormal bone turnover in cystic fibrosis adults. Osteoporos Int 2002; 13:151-7.
21. Aris RM, Stephens AR, Ontjes DA, et al. Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis. Am J Respir Crit Care Med 2000; 162:1674-8.
22. Gibbens DT, Gilsanz V, Boechat MI, Dufer D, Carlson ME, Wang CI. Osteoporosis in cystic fibrosis. J Pediatr 1988; 113:295-300.
23. Gronowitz E, Garemo M, Lindblad A, Mellstrom D, Strandvik B. Decreased bone mineral density in normal-growing patients with cystic fibrosis. Acta Paediatr 2003; 92:688-93.
24. Conway SP, Morton AM, Oldroyd B, et al. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 2000; 55:798-804.
25. Haworth CS, Selby PL, Webb AK, et al. Low bone mineral density in adults with cystic fibrosis. Thorax 1999; 54:961-7.
26. Donovan DS, Jr., Papadopoulos A, Staron RB, et al. Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med 1998; 157:1892-9.
27. Bachrach LK, Loutit CW, Moss RB. Osteopenia in adults with cystic fibrosis. Am J Med 1994; 96:27-34.
28. Haworth CS, Selby PL, Webb AK, Mawer EB, Adams JE, Freemont TJ. Severe bone pain after intravenous pamidronate in adult patients with cystic fibrosis. Lancet 1998; 352:1753-4.
29. Conway SP, Oldroyd B, Morton A, Truscott JG, Peckham DG. Effect of oral bisphosphonates on bone mineral density and body composition in adult patients with cystic fibrosis: a pilot study. Thorax 2004; 59:699-703.